Status:
COMPLETED
Photobiomodulation and Parkinson
Lead Sponsor:
University of Oviedo
Conditions:
Parkinson Disease
Eligibility:
All Genders
Phase:
NA
Brief Summary
This study aimed to assess the effects of transcranial photobiomodulation in patients with Parkinson's disease (PD).
Detailed Description
Thirty-five patients with idiopathic PD were randomly assigned to a photobiomodulation (n=17, \[mean±SD\] 72±7 years) or sham group (n=18, 70±8 years) during 9 weeks (2 sessions/week). The primary end...
Eligibility Criteria
Inclusion
- Having been diagnosed with idiopathic PD.
- Stage 1-2 on the Hoehn and Yahr Scale.
- Having no neurological condition other than PD.
- Being able to stand for 2 minutes and walk 10 meters without assistance.
- Having no severe dyskinesias or "ON-OFF" phases.
Exclusion
- \- Do not follow inclusion criteria.
Key Trial Info
Start Date :
January 29 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 30 2018
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT03811613
Start Date
January 29 2018
End Date
March 30 2018
Last Update
May 21 2025
Active Locations (2)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Physical Education and Sport, University of León
León, Castille and León, Spain, 24071
2
University School of Sports Medicine, University of Oviedo, Spain.
Oviedo, Principality of Asturias, Spain, 33005